Cited by 51Multiple Sclerosis Research StudiesPolyomavirus and related diseasesCerebrovascular and genetic disorders

Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis

Open access
Gabelic, T., Ramasamy, D.P., Weinstock-Guttman, B., Hagemeier, J., Kennedy, C., Melia, R., Hojnacki, D., Ramanathan, M. +1 more·2014·American Journal of Neuroradiology

Abstract

BACKGROUND AND PURPOSE: The exact prevalence of WM signal abnormalities in healthy relatives of MS patients and their impact on disease development has not been fully elucidated. The purpose of this study was to compare WM signal abnormality characteristics and the prevalence of radiologically isolated syndrome in healthy control subjects selected randomly from the population with the healthy relatives of patients with MS. MATERIALS AND METHODS: Healthy control subjects (n = 150) underwent physical and 3T MR imaging examinations. Healthy control subjects were classified as non-familial healthy control subjects (n = 82) if they had no family history of MS or as healthy relatives of patients with MS (n = 68) if they had ≥1 relative affected with MS. The presence of radiologically isolated syndrome was evaluated according to the Okuda criteria; dissemination in space on MR imaging and fulfillment of radiologically isolated syndrome criteria were also evaluated according to Swanton criteria. RESULTS: There was a significantly higher total volume of WM signal abnormality in the healthy relatives of patients with MS compared with the non-familial healthy control subjects (P = .024 for signal abnormality ≥3 mm in size and P = .025 for all sizes). Periventricular localization and the number of lesions in all groups (P = .034 and P = .043) were significantly higher in the healthy relatives of patients with MS; 8.8% of the healthy relatives of patients with MS and 4.9% of non-familial healthy control subjects showed ≥9 WM signal abnormalities; 2.9% of subjects in the healthy relatives of patients with MS group and 2.4% of non-familial healthy control subjects fulfilled radiologically isolated syndrome according to the Okuda criteria, whereas 10.3% and 3.7% of subjects fulfilled radiologically isolated syndrome according to the Swanton criteria. In the healthy relatives of patients with MS, smoking was associated with the presence of WM signal abnormalities, whereas obesity was related to the presence of ≥9 WM signal abnormalities and to fulfillment of radiologically isolated syndrome according to the Swanton criteria. CONCLUSIONS: The frequency of WM signal abnormalities and radiologically isolated syndrome is higher in the healthy relatives of patients with multiple sclerosis patients compared with non-familial healthy control subjects.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3174/ajnr.a3653

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Approximately one-third of RIS cases are diagnosed with MS within five years of presentation.

    “Approximately one-third of RIS cases are diagnosed with MS within five years of presentation, most often with a relapsingremitting course 83,86 but occasionally with a primary progressive course. 87,88”

    From Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria (2018) · cites this paper as [86]

    The Discussion (page unavailable) says this was a cross-sectional pilot study with no longitudinal follow-up data and that a five-year follow-up was planned. Searches for five-year RIS-to-MS conversion and a one-third conversion rate found no passage reporting that estimate; the paper reports RIS prevalence instead. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • RIS conversion to MS is most often with a relapsing-remitting course but occasionally with a primary progressive course.

    “Approximately one-third of RIS cases are diagnosed with MS within five years of presentation, most often with a relapsingremitting course 83,86 but occasionally with a primary progressive course. 87,88”

    From Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria (2018) · cites this paper as [86]

    The Discussion says this was a cross-sectional pilot study with no longitudinal follow-up of its participants; a five-year follow-up was planned. Our copy does not report whether people with RIS developed relapsing-remitting or primary progressive MS (searched: primary progressive course, relapsing-remitting conversion). (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 35

  1. Weinshenker BG, Bulman D, Carriere W, et al. A comparison of spo- radic and familial multiple sclerosis. Neurology 1990;40:1354 -58
  2. Siger-Zajdel M, Filippi M, Selmaj K. MTR discloses subtle changes in the normal-appearing tissue from relatives of patients with MS. Neurology 2002;58:317-20
  3. O'Gorman C, Lin R, Stankovich J, et al. Modelling genetic suscepti- bility to multiple sclerosis with family data. Neuroepidemiology 2013;40:1-12
  4. Sadovnick AD, Yee IM, Ebers GC, et al. Effect of age at onset and parental disease status on sibling risks for MS. Neurology 1998;50:719 -23
  5. Prokopenko I, Montomoli C, Ferrai R, et al. Risk for relatives of patients with multiple sclerosis in central Sardinia, Italy. Neuroepi- demiology 2003;22:290 -96
  6. Hensiek AE, Seaman SR, Barcellos LF, et al. Familial effects on the clinical course of multiple sclerosis. Neurology 2007;68:376 -83
  7. Siger-Zajdel M, Selmaj K. Magnetisation transfer ratio analysis of nor- mal appearing white matter in patients with familial and sporadic multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;71:752-56
  8. Siger-Zajdel M, Selmaj KW. Proton magnetic resonance spectros- copy of normal appearing white matter in familial and sporadic multiple sclerosis. J Neurol 2005;252:830 -32
  9. Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anoma- lies suggestive of multiple sclerosis: the radiologically isolated syn- drome. Neurology 2009;72:800 -05
  10. Granberg T, Martola J, Kristoffersen-Wiberg M, et al. Radiologically isolated syndrome: incidental magnetic resonance imaging find- ings suggestive of multiple sclerosis, a systematic review. Mult Scler 2013;19:271-80
  11. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302
  12. Swanton JK, Fernando K, Dalton CM, et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2006;77:830 -33
  13. De Stefano N, Stromillo ML, Rossi F, et al. Improving the character- ization of radiologically isolated syndrome suggestive of multiple sclerosis. PLoS One 2011;6:e19452
  14. Filippi M, Campi A, Martino G, et al. A magnetization transfer study of white matter in siblings of multiple sclerosis patients. J Neurol Sci 1997;147:151-53
  15. De Stefano N, Cocco E, Lai M, et al. Imaging brain damage in first- degree relatives of sporadic and familial multiple sclerosis. Ann Neurol 2006;59:634 -39
  16. Tienari PJ, Salonen O, Wikstrom J, et al. Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings. J Neurol Neurosurg Psychiatry 1992;55:883-86
  17. Lynch SG, Rose JW, Smoker W, et al. MRI in familial multiple scle- rosis. Neurology 1990;40:900 -03
  18. Dolic K, Weinstock-Guttman B, Marr K, et al. Risk factors for chronic cerebrospinal venous insufficiency (CCSVI) in a large co- hort of volunteers. PLoS One 2011;6:e28062
  19. Jenkinson M, Bannister P, Brady M, et al. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002;17:825-41
  20. Zivadinov R, Rudick RA, De Masi R, et al. Effects of IV methylpred- nisolone on brain atrophy in relapsing-remitting MS. Neurology 2001;57:1239 -47
  21. Seewann A, Vrenken H, van der Valk P, et al. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopatho- logic analysis. Arch Neurol 2009;66:601-09
  22. Langer-Gould A, Brara S, Beaber B, et al. Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology 2013;80:548 -52
  23. Morris Z, Whiteley WN, Longstreth WT Jr, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta- analysis. BMJ 2009;339:b3016
  24. Weber F, Knopf H. Incidental findings in magnetic resonance imaging of the brains of healthy young men. J Neurol Sci 2006;240:81-84
  25. Engell T. A clinical patho-anatomical study of clinically silent mul- tiple sclerosis. Acta Neurol Scand 1989;79:428 -30
  26. Wasay M, Rizvi F, Azeemuddin M, et al. Incidental MRI lesions sug- gestive of multiple sclerosis in asymptomatic patients in Karachi, Pakistan. J Neurol Neurosurg Psychiatry 2011;82:83-85
  27. D'Amico D, La Mantia L, Rigamonti A, et al. Prevalence of primary head- aches in people with multiple sclerosis. Cephalalgia 2004;24:980-84
  28. Di Perri C, Dwyer MG, Wack DS, et al. Signal abnormalities on 1.5 and 3 Tesla brain MRI in multiple sclerosis patients and healthy controls: a morphological and spatial quantitative comparison study. Neuroimage 2009;47:1352-62
  29. Sicotte NL, Voskuhl RR, Bouvier S, et al. Comparison of multiple sclerosis lesions at 1.5 and 3.0 Tesla. Invest Radiol 2003;38:423-27
  30. Stankiewicz JM, Glanz BI, Healy BC, et al. Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis. J Neuroim- aging 2011;21:e50 -56
  31. Enzinger C, Smith S, Fazekas F, et al. Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention study. J Neurol 2006;253:1064 -70
  32. Gouw AA, Seewann A, van der Flier WM, et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011;82:126 -35
  33. Laule C, Pavlova V, Leung E, et al. Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration. J Neuropathol Exp Neurol 2013;72:42-52
  34. Lebrun C, Bensa C, Debouverie M, et al. Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry 2008;79:195-98
  35. Okuda DT, Mowry EM, Cree BA, et al. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syn- drome. Neurology 2011;76:686 -92

Cited by

Sorted by citations

Authors
Gabelic, T., Ramasamy, D. P., Weinstock-Guttman, B., Hagemeier, J., Kennedy, C., Melia, R., Hojnacki, D., Ramanathan, M., & Zivadinov, R.
Affiliations
University at Buffalo, State University of New York (US)
Venue
American Journal of Neuroradiology
Published
2013-07-25
Volume
35
Issue
1
Pages
106-112
ISSN
  • 0195-6108 (ISSN-L)
  • 1936-959X
OpenAlex
W2123372270
Cited by
51
References
2
Citations by year
2026: 1 · 2023: 5 · 2022: 2 · 2021: 7 · 2020: 5 · 2019: 6 · 2018: 4 · 2017: 4 · 2016: 5 · 2015: 6 · 2014: 4 · 2013: 2
FWCI
4.25
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • American Journal of Neuroradiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
  • Health Sciences › Medicine › Neurology › Cerebrovascular and genetic disorders
Keywords
radiologically isolated syndrome, multiple sclerosis, white matter signal abnormalities, familial risk, periventricular lesions, dissemination in space, smoking, obesity
MeSH terms
Adult, Female, Humans, Magnetic Resonance Imaging, Male, Multiple Sclerosis, Nerve Fibers, Myelinated, New York, Reference Values, Risk Factors, Sensitivity and Specificity, Syndrome, Reproducibility of Results, Prevalence, Sex Distribution, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review